(continued)
- Enflonsia (clesrovimab-cfor)
- Turalio (Pexidartinib)
- Prolastin-C (alpha-1-proteinase inhibitor)
- Tukysa (tucatinib)
- Lapatinib (Tykerb)
- Bronchitol (mannitol)
- Pulmozyme (dornase alfa)
- Cabazitaxel (Jevtana)
- Eribulin (Halaven)
- Iclusig (Ponatinib)
- Mylotarg (Gemtuzumab)
- Jelmyto (mitomycin pyelocalyceal)
- Mitomycin (Mutamycin, Mitomycin C)
- Sorafenib (Nexavar)
- Octreotide (Sandostatin, Bynfezia)
- Tivdak (Tisotumab-Vedotin-Tftv)
- Zynyz (retifanlimab-dlwr)
- Dactinomycin (Cosmegen)
- Adcetris (Brentuximab Vedotin)
- Lanreotide (Somatuline Depot)
- Ixempra (ixabepilone)
- Padcev (enfortumab vedotin-ejfv)
- Bleomycin (Blenoxane)
- Opsynvi (macitentan/tadalafil)
- Welireg (belzutifan)
- Signifor (pasireotide)
- Ambrisentan (Letairis)
- Bosentan (Tracleer)
- Tryptyr (acoltremon)
- Ovidrel (choriogonadotropin alfa)
- How Talvey Works to Treat Multiple Myeloma
- What to Know About Lutathera for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
- What to Know About Imfinzi for Non-Small-Cell Lung Cancer
- What to Know About Imfinzi for Biliary Tract Cancer
- What to Know About Erleada for Prostate Cancer
- Navigating Prostate Cancer: What to Know About Nubeqa
- Saphnelo for Lupus
- Benlysta for Lupus
- Adbry for Atopic Dermatitis: What You Need to Know
- Treating Breast Cancer with Trodelvy – What You Need to Know
- Navigating Psoriatic Arthritis With Otezla: What You Need to Know
- Navigating Psoriasis With Otezla: What You Need to Know
- Myfembree for Uterine Fibroids and Endometriosis
- Caplyta for Schizophrenia and Bipolar Depression